OR WAIT null SECS
Felicity Thomas is Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.
November 03, 2020
Amorphous solid dispersions are a useful tool in overcoming solubility issues, but they have not yet reached full potential in commercial success.
Bio/pharma continues preparations for a no-deal scenario as time for the UK and EU to agree upon a new deal runs out.
November 02, 2020
Industry wants clarification on compliance following the end of the Brexit transition period.
October 03, 2020
More complex and challenging compounds require a more tailored approach to formulation strategies.
Taste-masking can be of significant importance in ensuring success of a drug product, particularly those targeted to pediatric or geriatric populations.
October 02, 2020
A comprehensive rewrite of Annex 1 has been proposed and aims to organize and structure requirements in 10 specific sections.